tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
DiaMedica Therapeutics initiated with an Overweight at Cantor Fitzgerald
PremiumThe FlyDiaMedica Therapeutics initiated with an Overweight at Cantor Fitzgerald
2M ago
DiaMedica Therapeutics Reports Q3 2025 Financial Results
Premium
Company Announcements
DiaMedica Therapeutics Reports Q3 2025 Financial Results
2M ago
DiaMedica Therapeutics’ Earnings Call: Mixed Outlook
Premium
Company Announcements
DiaMedica Therapeutics’ Earnings Call: Mixed Outlook
2M ago
Buy Rating for Diamedica Therapeutics: Promising Potential of DM199 in Preeclampsia Treatment
PremiumRatingsBuy Rating for Diamedica Therapeutics: Promising Potential of DM199 in Preeclampsia Treatment
2M ago
ReMEDy2 Trial: A Potential Game-Changer for Acute Ischemic Stroke Treatment
Premium
Company Announcements
ReMEDy2 Trial: A Potential Game-Changer for Acute Ischemic Stroke Treatment
2M ago
DiaMedica Therapeutics’ Earnings Call Highlights Progress and Challenges
Premium
Company Announcements
DiaMedica Therapeutics’ Earnings Call Highlights Progress and Challenges
4M ago
DiaMedica Therapeutics reports Q2 EPS (18c), consensus (19c)
PremiumThe FlyDiaMedica Therapeutics reports Q2 EPS (18c), consensus (19c)
5M ago
DMAC Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
DMAC Earnings Report this Week: Is It a Buy, Ahead of Earnings?
5M ago
DiaMedica Therapeutics CMO Lorianne Masuoka resigns, Julie Krop succeeds
Premium
The Fly
DiaMedica Therapeutics CMO Lorianne Masuoka resigns, Julie Krop succeeds
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100